[{"Assets_0_Q1_USD":235026000.0,"CommonStockSharesOutstanding_0_Q1_shares":31888998.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":48610000.0,"NetIncomeLoss_1_Q1_USD":-19926000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":942000.0,"StockholdersEquity_0_Q1_USD":98293000.0,"Ticker":"VYGR","CIK":"1640266","name":"VOYAGER THERAPEUTICS, INC.","OfficialName":"Voyager Therapeutics Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"363614047.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180510"}]